Advances in Lipid Nanoparticles for mRNA-Based Cancer Immunotherapy

Advances in Lipid Nanoparticles for mRNA-Based Cancer Immunotherapy

Over the past decade, messenger RNA (mRNA) has emerged as potent and flexible platform for the development of novel effective cancer immunotherapies. Advances in non-viral gene delivery technologies, especially the tremendous progress in lipid nanoparticles' manufacturing, have made possible th...

Full description

Bibliographic Details
Main Authors: Maria L. Guevara, Francesca Persano, Stefano Persano
Format: Article
Language:English
Published: Frontiers Media S.A. 2020-10-01
Series:Frontiers in Chemistry
Subjects:
monoclonal antibodies
CAR T cells
cancer vaccines
lipid nanoparticles
therapeutic mRNA
cancer immunotherapy
Online Access:https://www.frontiersin.org/articles/10.3389/fchem.2020.589959/full

Internet

https://www.frontiersin.org/articles/10.3389/fchem.2020.589959/full

Similar Items